Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients
- 31 January 1995
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 44, 6-14
- https://doi.org/10.1016/0026-0495(95)90304-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serumFEBS Letters, 1994
- Long-term efficacy and tolerability of octreotide treatment in acromegalyMetabolism, 1992
- Gallstones during octreotide therapyMetabolism, 1992
- A comparison of octreotide delivered by continuous subcutaneous infusion with intermittent injection in the treatment of acromegalyEuropean Journal of Clinical Investigation, 1992
- A randomized comparison of intranasal and injectable octreotide administration in patients with acromegalyJournal of Clinical Endocrinology & Metabolism, 1992
- SMS 201-995 and Thyroid Function in Acromegaly:Hormone and Metabolic Research, 1992
- Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patientsClinical Endocrinology, 1992
- OCTREOTIDE STIMULATES INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 (IGFBP-1) LEVELS IN ACROMEGALYJournal of Clinical Endocrinology & Metabolism, 1991
- Effects of antibodies against octreotide in two patients with acromegalyClinical Endocrinology, 1991
- Clinical Applications of Somatostatin AnalogsAdvances in experimental medicine and biology, 1985